Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
08/27/2010
Trade Name:
Augmentin XR
Generic Name or Proper Name (*):
amoxicillin/clavulanate potassium
Indications Studied:
Community-acquired pneumonia or acute bacterial sinusitis
Label Changes Summary:
* Expanded indication from adults to children weighing e 40 kg who are able to swallow tablets * Use in children is supported by evidence from trials of adults with additional data from a pediatric PK study * Adverse events similar to adults * Information on dose, and PK parameters * Information added to Clinical Pharmacology and Pediatric Use
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
GlaxoSmithKline
NNPS:
FALSE
Therapeutic Category:
Antibiotic
-
-